NMN (Nicotinamide Mononucleotide) vs TUDCA (Tauroursodeoxycholic Acid)

Mechanism

NMN is a direct biosynthetic precursor to NAD+ via the salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT). Elevated NAD+ activates sirtuins (SIRT1-7), PARP DNA repair enzymes, and CD38/CD157 signaling. SIRT1 activation deacetylates PGC-1alpha (mitochondrial biogenesis), FOXO transcription factors (stress resistance), and NF-kB (anti-inflammatory). NMN also enters cells via the Slc12a8 transporter, recently identified in the gut.

Standard Dosing

500-1000mg daily

Timing

Morning on empty stomach. Sublingual absorption bypasses first-pass metabolism.

Cycle Duration

ongoing

Side Effects

• Mild GI discomfort
• Flushing (rare, unlike niacin)
• Mild headache during initial use

Contraindications

• Active cancer (theoretical concern: NAD+ may fuel rapidly dividing cells)
• Pregnancy/lactation (insufficient data)
• Theoretical concern in active cancer (NAD+ fuels all rapidly dividing cells)

Best Stacking Partners

Mechanism

TUDCA is a water-soluble bile acid conjugate (taurine + ursodeoxycholic acid) with potent hepatoprotective and cytoprotective properties. It inhibits the mitochondrial pathway of apoptosis by preventing BAX translocation to mitochondria and cytochrome c release. TUDCA reduces endoplasmic reticulum (ER) stress by acting as a chemical chaperone, assisting protein folding and reducing the unfolded protein response (UPR). It protects hepatocytes by stabilizing cell membranes, displacing toxic hydrophobic bile acids (chenodeoxycholic, lithocholic) from biliary epithelium, and promoting choleresis (bile flow). Additionally, it has neuroprotective effects via reduction of ER stress in neurons and modulation of the TGR5 bile acid receptor.

Standard Dosing

250-500mg daily

Timing

With meals for liver support. Some protocols recommend before meals to prime bile flow.

Cycle Duration

Cycle 4-8 weeks for liver support; ongoing at low dose for chronic liver conditions under supervision

Side Effects

• Diarrhea (dose-dependent)
• GI discomfort
• Flatulence
• Rare: calcification of gallstones

Contraindications

• Complete biliary obstruction (cannot reach bile ducts if obstruction is complete)
• Calcified gallstones (UDCA/TUDCA dissolve cholesterol stones, not calcified)
• Acute cholangitis
• Complete biliary obstruction
• Gallstones (may mobilize stones)

Best Stacking Partners